カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のバイオ医薬品用前臨床断層撮影システム市場2022年：CT、SPECT、その他

◆英語タイトル：Global Preclinical Tomography System for Biopharmaceuticals Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8318 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：94 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

バイオ医薬品用前臨床断層撮影システム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のバイオ医薬品用前臨床断層撮影システムの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

バイオ医薬品用前臨床断層撮影システム市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・CT、SPECT、その他

用途別セグメントは次のように区分されます。
・病院、研究所、その他

世界のバイオ医薬品用前臨床断層撮影システム市場の主要な市場プレーヤーは以下のとおりです。
・Bruker、MR Solutions、Scanco Medical、PerkinElmer、Trifoil Imaging、Mediso、Sedecal、MILabs

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、バイオ医薬品用前臨床断層撮影システム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なバイオ医薬品用前臨床断層撮影システムメーカーの企業概要、2019年～2022年までのバイオ医薬品用前臨床断層撮影システムの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なバイオ医薬品用前臨床断層撮影システムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別バイオ医薬品用前臨床断層撮影システムの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのバイオ医薬品用前臨床断層撮影システムの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのバイオ医薬品用前臨床断層撮影システム市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびバイオ医薬品用前臨床断層撮影システムの産業チェーンを掲載しています。
・第13、14、15章では、バイオ医薬品用前臨床断層撮影システムの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Bruker、MR Solutions、Scanco Medical、PerkinElmer、Trifoil Imaging、Mediso、Sedecal、MILabs
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：CT、SPECT、その他
・用途別分析2017年-2028年：病院、研究所、その他
・バイオ医薬品用前臨床断層撮影システムの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・バイオ医薬品用前臨床断層撮影システムのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・バイオ医薬品用前臨床断層撮影システムのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・バイオ医薬品用前臨床断層撮影システムの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・バイオ医薬品用前臨床断層撮影システムの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Preclinical Tomography System for Biopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Preclinical Tomography System for Biopharmaceuticals market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Preclinical Tomography System for Biopharmaceuticals global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While CT segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Preclinical Tomography System for Biopharmaceuticals include Bruker, MR Solutions, Scanco Medical, PerkinElmer, and Trifoil Imaging, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Preclinical Tomography System for Biopharmaceuticals market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CT
SPECT
Others
Market segment by Application can be divided into
Hospital
Research Institute
Other
The key market players for global Preclinical Tomography System for Biopharmaceuticals market are listed below:
Bruker
MR Solutions
Scanco Medical
PerkinElmer
Trifoil Imaging
Mediso
Sedecal
MILabs
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Preclinical Tomography System for Biopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Preclinical Tomography System for Biopharmaceuticals, with price, sales, revenue and global market share of Preclinical Tomography System for Biopharmaceuticals from 2019 to 2022.
Chapter 3, the Preclinical Tomography System for Biopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Preclinical Tomography System for Biopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Preclinical Tomography System for Biopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Preclinical Tomography System for Biopharmaceuticals.
Chapter 13, 14, and 15, to describe Preclinical Tomography System for Biopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Preclinical Tomography System for Biopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Preclinical Tomography System for Biopharmaceuticals Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 CT
1.2.3 SPECT
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Preclinical Tomography System for Biopharmaceuticals Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Other
1.4 Global Preclinical Tomography System for Biopharmaceuticals Market Size & Forecast
1.4.1 Global Preclinical Tomography System for Biopharmaceuticals Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Preclinical Tomography System for Biopharmaceuticals Sales in Volume (2017-2028)
1.4.3 Global Preclinical Tomography System for Biopharmaceuticals Price (2017-2028)
1.5 Global Preclinical Tomography System for Biopharmaceuticals Production Capacity Analysis
1.5.1 Global Preclinical Tomography System for Biopharmaceuticals Total Production Capacity (2017-2028)
1.5.2 Global Preclinical Tomography System for Biopharmaceuticals Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Preclinical Tomography System for Biopharmaceuticals Market Drivers
1.6.2 Preclinical Tomography System for Biopharmaceuticals Market Restraints
1.6.3 Preclinical Tomography System for Biopharmaceuticals Trends Analysis
2 Manufacturers Profiles
2.1 Bruker
2.1.1 Bruker Details
2.1.2 Bruker Major Business
2.1.3 Bruker Preclinical Tomography System for Biopharmaceuticals Product and Services
2.1.4 Bruker Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 MR Solutions
2.2.1 MR Solutions Details
2.2.2 MR Solutions Major Business
2.2.3 MR Solutions Preclinical Tomography System for Biopharmaceuticals Product and Services
2.2.4 MR Solutions Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Scanco Medical
2.3.1 Scanco Medical Details
2.3.2 Scanco Medical Major Business
2.3.3 Scanco Medical Preclinical Tomography System for Biopharmaceuticals Product and Services
2.3.4 Scanco Medical Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 PerkinElmer
2.4.1 PerkinElmer Details
2.4.2 PerkinElmer Major Business
2.4.3 PerkinElmer Preclinical Tomography System for Biopharmaceuticals Product and Services
2.4.4 PerkinElmer Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Trifoil Imaging
2.5.1 Trifoil Imaging Details
2.5.2 Trifoil Imaging Major Business
2.5.3 Trifoil Imaging Preclinical Tomography System for Biopharmaceuticals Product and Services
2.5.4 Trifoil Imaging Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Mediso
2.6.1 Mediso Details
2.6.2 Mediso Major Business
2.6.3 Mediso Preclinical Tomography System for Biopharmaceuticals Product and Services
2.6.4 Mediso Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sedecal
2.7.1 Sedecal Details
2.7.2 Sedecal Major Business
2.7.3 Sedecal Preclinical Tomography System for Biopharmaceuticals Product and Services
2.7.4 Sedecal Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 MILabs
2.8.1 MILabs Details
2.8.2 MILabs Major Business
2.8.3 MILabs Preclinical Tomography System for Biopharmaceuticals Product and Services
2.8.4 MILabs Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Preclinical Tomography System for Biopharmaceuticals Breakdown Data by Manufacturer
3.1 Global Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Preclinical Tomography System for Biopharmaceuticals Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Preclinical Tomography System for Biopharmaceuticals
3.4 Market Concentration Rate
3.4.1 Top 3 Preclinical Tomography System for Biopharmaceuticals Manufacturer Market Share in 2021
3.4.2 Top 6 Preclinical Tomography System for Biopharmaceuticals Manufacturer Market Share in 2021
3.5 Global Preclinical Tomography System for Biopharmaceuticals Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Preclinical Tomography System for Biopharmaceuticals Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Preclinical Tomography System for Biopharmaceuticals Market Size by Region
4.1.1 Global Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Region (2017-2028)
4.1.2 Global Preclinical Tomography System for Biopharmaceuticals Revenue by Region (2017-2028)
4.2 North America Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028)
4.3 Europe Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028)
4.4 Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028)
4.5 South America Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028)
4.6 Middle East and Africa Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Type (2017-2028)
5.2 Global Preclinical Tomography System for Biopharmaceuticals Revenue by Type (2017-2028)
5.3 Global Preclinical Tomography System for Biopharmaceuticals Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Application (2017-2028)
6.2 Global Preclinical Tomography System for Biopharmaceuticals Revenue by Application (2017-2028)
6.3 Global Preclinical Tomography System for Biopharmaceuticals Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2028)
7.2 North America Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2028)
7.3 North America Preclinical Tomography System for Biopharmaceuticals Market Size by Country
7.3.1 North America Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Country (2017-2028)
7.3.2 North America Preclinical Tomography System for Biopharmaceuticals Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2028)
8.2 Europe Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2028)
8.3 Europe Preclinical Tomography System for Biopharmaceuticals Market Size by Country
8.3.1 Europe Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Country (2017-2028)
8.3.2 Europe Preclinical Tomography System for Biopharmaceuticals Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2028)
9.2 Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2028)
9.3 Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2028)
10.2 South America Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2028)
10.3 South America Preclinical Tomography System for Biopharmaceuticals Market Size by Country
10.3.1 South America Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Country (2017-2028)
10.3.2 South America Preclinical Tomography System for Biopharmaceuticals Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2028)
11.2 Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2028)
11.3 Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Preclinical Tomography System for Biopharmaceuticals and Key Manufacturers
12.2 Manufacturing Costs Percentage of Preclinical Tomography System for Biopharmaceuticals
12.3 Preclinical Tomography System for Biopharmaceuticals Production Process
12.4 Preclinical Tomography System for Biopharmaceuticals Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Preclinical Tomography System for Biopharmaceuticals Typical Distributors
13.3 Preclinical Tomography System for Biopharmaceuticals Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Preclinical Tomography System for Biopharmaceuticals Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Preclinical Tomography System for Biopharmaceuticals Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bruker Basic Information, Manufacturing Base and Competitors
Table 4. Bruker Major Business
Table 5. Bruker Preclinical Tomography System for Biopharmaceuticals Product and Services
Table 6. Bruker Preclinical Tomography System for Biopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. MR Solutions Basic Information, Manufacturing Base and Competitors
Table 8. MR Solutions Major Business
Table 9. MR Solutions Preclinical Tomography System for Biopharmaceuticals Product and Services
Table 10. MR Solutions Preclinical Tomography System for Biopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Scanco Medical Basic Information, Manufacturing Base and Competitors
Table 12. Scanco Medical Major Business
Table 13. Scanco Medical Preclinical Tomography System for Biopharmaceuticals Product and Services
Table 14. Scanco Medical Preclinical Tomography System for Biopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. PerkinElmer Basic Information, Manufacturing Base and Competitors
Table 16. PerkinElmer Major Business
Table 17. PerkinElmer Preclinical Tomography System for Biopharmaceuticals Product and Services
Table 18. PerkinElmer Preclinical Tomography System for Biopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Trifoil Imaging Basic Information, Manufacturing Base and Competitors
Table 20. Trifoil Imaging Major Business
Table 21. Trifoil Imaging Preclinical Tomography System for Biopharmaceuticals Product and Services
Table 22. Trifoil Imaging Preclinical Tomography System for Biopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Mediso Basic Information, Manufacturing Base and Competitors
Table 24. Mediso Major Business
Table 25. Mediso Preclinical Tomography System for Biopharmaceuticals Product and Services
Table 26. Mediso Preclinical Tomography System for Biopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sedecal Basic Information, Manufacturing Base and Competitors
Table 28. Sedecal Major Business
Table 29. Sedecal Preclinical Tomography System for Biopharmaceuticals Product and Services
Table 30. Sedecal Preclinical Tomography System for Biopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. MILabs Basic Information, Manufacturing Base and Competitors
Table 32. MILabs Major Business
Table 33. MILabs Preclinical Tomography System for Biopharmaceuticals Product and Services
Table 34. MILabs Preclinical Tomography System for Biopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Preclinical Tomography System for Biopharmaceuticals Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Preclinical Tomography System for Biopharmaceuticals Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Preclinical Tomography System for Biopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Preclinical Tomography System for Biopharmaceuticals Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Preclinical Tomography System for Biopharmaceuticals Production Site of Key Manufacturer
Table 40. Preclinical Tomography System for Biopharmaceuticals New Entrant and Capacity Expansion Plans
Table 41. Preclinical Tomography System for Biopharmaceuticals Mergers & Acquisitions in the Past Five Years
Table 42. Global Preclinical Tomography System for Biopharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 43. Global Preclinical Tomography System for Biopharmaceuticals Sales by Region (2023-2028) & (K Units)
Table 44. Global Preclinical Tomography System for Biopharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Preclinical Tomography System for Biopharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 47. Global Preclinical Tomography System for Biopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 48. Global Preclinical Tomography System for Biopharmaceuticals Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Preclinical Tomography System for Biopharmaceuticals Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Preclinical Tomography System for Biopharmaceuticals Price by Type (2017-2022) & (US$/Unit)
Table 51. Global Preclinical Tomography System for Biopharmaceuticals Price by Type (2023-2028) & (US$/Unit)
Table 52. Global Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 53. Global Preclinical Tomography System for Biopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 54. Global Preclinical Tomography System for Biopharmaceuticals Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Preclinical Tomography System for Biopharmaceuticals Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Preclinical Tomography System for Biopharmaceuticals Price by Application (2017-2022) & (US$/Unit)
Table 57. Global Preclinical Tomography System for Biopharmaceuticals Price by Application (2023-2028) & (US$/Unit)
Table 58. North America Preclinical Tomography System for Biopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 59. North America Preclinical Tomography System for Biopharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 60. North America Preclinical Tomography System for Biopharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Preclinical Tomography System for Biopharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 63. North America Preclinical Tomography System for Biopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 64. North America Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 65. North America Preclinical Tomography System for Biopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 66. Europe Preclinical Tomography System for Biopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 67. Europe Preclinical Tomography System for Biopharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 68. Europe Preclinical Tomography System for Biopharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Preclinical Tomography System for Biopharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 71. Europe Preclinical Tomography System for Biopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 72. Europe Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 73. Europe Preclinical Tomography System for Biopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 82. South America Preclinical Tomography System for Biopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 83. South America Preclinical Tomography System for Biopharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 84. South America Preclinical Tomography System for Biopharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Preclinical Tomography System for Biopharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 87. South America Preclinical Tomography System for Biopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 88. South America Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 89. South America Preclinical Tomography System for Biopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 98. Preclinical Tomography System for Biopharmaceuticals Raw Material
Table 99. Key Manufacturers of Preclinical Tomography System for Biopharmaceuticals Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Preclinical Tomography System for Biopharmaceuticals Typical Distributors
Table 103. Preclinical Tomography System for Biopharmaceuticals Typical Customers
List of Figures
Figure 1. Preclinical Tomography System for Biopharmaceuticals Picture
Figure 2. Global Preclinical Tomography System for Biopharmaceuticals Revenue Market Share by Type in 2021
Figure 3. CT
Figure 4. SPECT
Figure 5. Others
Figure 6. Global Preclinical Tomography System for Biopharmaceuticals Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Research Institute
Figure 9. Other
Figure 10. Global Preclinical Tomography System for Biopharmaceuticals Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Preclinical Tomography System for Biopharmaceuticals Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Preclinical Tomography System for Biopharmaceuticals Sales (2017-2028) & (K Units)
Figure 13. Global Preclinical Tomography System for Biopharmaceuticals Price (2017-2028) & (US$/Unit)
Figure 14. Global Preclinical Tomography System for Biopharmaceuticals Production Capacity (2017-2028) & (K Units)
Figure 15. Global Preclinical Tomography System for Biopharmaceuticals Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Preclinical Tomography System for Biopharmaceuticals Market Drivers
Figure 17. Preclinical Tomography System for Biopharmaceuticals Market Restraints
Figure 18. Preclinical Tomography System for Biopharmaceuticals Market Trends
Figure 19. Global Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Manufacturer in 2021
Figure 20. Global Preclinical Tomography System for Biopharmaceuticals Revenue Market Share by Manufacturer in 2021
Figure 21. Preclinical Tomography System for Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Preclinical Tomography System for Biopharmaceuticals Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Preclinical Tomography System for Biopharmaceuticals Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 25. Global Preclinical Tomography System for Biopharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 26. North America Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 27. Europe Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 29. South America Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 31. Global Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 32. Global Preclinical Tomography System for Biopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 33. Global Preclinical Tomography System for Biopharmaceuticals Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 35. Global Preclinical Tomography System for Biopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 36. Global Preclinical Tomography System for Biopharmaceuticals Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 38. North America Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 39. North America Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Country (2017-2028)
Figure 40. North America Preclinical Tomography System for Biopharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 41. United States Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 45. Europe Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 46. Europe Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Country (2017-2028)
Figure 47. Europe Preclinical Tomography System for Biopharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 48. Germany Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 57. China Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 64. South America Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 65. South America Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Country (2017-2028)
Figure 66. South America Preclinical Tomography System for Biopharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Preclinical Tomography System for Biopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Preclinical Tomography System for Biopharmaceuticals in 2021
Figure 78. Manufacturing Process Analysis of Preclinical Tomography System for Biopharmaceuticals
Figure 79. Preclinical Tomography System for Biopharmaceuticals Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のバイオ医薬品用前臨床断層撮影システム市場2022年：CT、SPECT、その他(Global Preclinical Tomography System for Biopharmaceuticals Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のバイオ医薬品用前臨床断層撮影システム市場2022年：CT、SPECT、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp